Education
About Us
Working with TipRanks
Follow Us
Emily Luisa Hill Insider Profile
4 Followers
Emily Luisa Hill, CFO at PTC Therapeutics, holds 134.37K shares in Replimune Group (Ticker: REPL), holds 38.92K shares in PTC Therapeutics (Ticker: PTCT). Most recently, Emily Luisa Hill Sold ― shares of Replimune Group on Aug 19, 2025 for an estimated value of $49.16K.
Profitable Transactions
9 out of 15 Profitable Transactions
Average Return
+17.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Emily Luisa Hill
Emily Luisa Hill's Trading History
PTC Therapeutics
Mar 29, 2023
CFO
Uninformative Sell
331.33K
$1.97M
Replimune Group
Aug 19, 2025
CFO
Informative Sell
49.16K
$761.87K
List of latest transactions for each holding click on a transaction to see Emily Luisa Hill's performance on stock
You May Also Like
Emily Luisa Hill insider profile FAQ
What is the percentage of profitable transactions made by Emily Luisa Hill?
The percentage of profitable transactions made by Emily Luisa Hill is 60%.
What is the average return per transaction made by Emily Luisa Hill?
The average return per transaction made by Emily Luisa Hill is 17.70%.
What stocks does Emily Luisa Hill hold?
Emily Luisa Hill holds: PTCT, REPL stocks.
What was Emily Luisa Hill’s latest transaction?
Emily Luisa Hill latest transaction was an Informative Sell of $49.16K.
What was Emily Luisa Hill's most profitable transaction?
Emily Luisa Hill’s most profitable transaction was an Informative Sell of PTCT stock on February 2, 2023. The return on the trade was 46.80%.
What is Emily Luisa Hill's role in PTC Therapeutics?
Emily Luisa Hill's role in PTC Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.